Europe — EMA
Oktreotid Teva (Octreotide Acetate)
Octreotide acetate, the active ingredient in Oktreotid Teva, is a synthetic somatostatin analogue presented as a solution for subcutaneous injection use.
Request sourcing
What is Octreotide Acetate?
Octreotide acetate, the active ingredient in Oktreotid Teva, is a synthetic somatostatin analogue presented as a solution for subcutaneous injection use. It regulates hormone secretion and controls symptoms in patients with certain endocrine tumours and related conditions. GNH USA supplies Oktreotid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Oktreotid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Octreotide Acetate used for?
Octreotide acetate … .... … .... ... … … .... .... .... … … .... ...
Product details
Related products

Sandostatin 50 ug/mL
Octreotide Acetate · 50 ug/mL

Sandostatin 100 ug/mL
Octreotide Acetate · 100 ug/mL

Sandostatin 500 ug/mL
Octreotide Acetate · 500 ug/mL

Octreotide Acetate 50 ug/mL
Octreotide Acetate · 50 ug/mL